期刊文献+

结核分枝杆菌休眠相关抗原Rv1733c DNA疫苗的构建及免疫学特性研究 被引量:2

Construction and immunogenicity of the DNA vaccine of dormancy related antigen Rv1733c of Mycobacterium tuberculosis
下载PDF
导出
摘要 目的构建结核分枝杆菌(Mtb)休眠相关抗原Rv1733c的真核表达载体,并评价其作为DNA疫苗的免疫学特性。方法利用限制性酶切的方法从本室前期保存的pMD-18T-Rv1733c质粒中构建Rv1733c的真核表达载体pcDNA-Rv1733c。将pcDNA-Rv1733c重组质粒稳定转染P815细胞,并用间接免疫荧光法检测Rv1733c的表达。采用数字表法随机将BALB/c小鼠分为3组,每组10只,即pcDNA-Rv1733c质粒DNA组、生理盐水组和BCG组。pcDNA-Rv1733c质粒DNA组和生理盐水组采用肌内注射方式免疫,间隔2周免疫1次,共免疫3次。BCG组采用皮下免疫一次。各组小鼠每2周采血,ELISA检测血清中特异性抗体水平和IgG2a/IgG1抗体亚类比率与比值。初次免疫8周后,MTS[3-(4,5-diethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Hetrazolium,inner salt](四氮唑蓝盐化合物)法检测小鼠脾淋巴细胞特异性增殖、ELISPOT检测脾淋巴细胞分泌IFN-γ的水平。流式细胞法检测脾淋巴细胞中CD4+和CD8+T细胞所占比率;LDH法检测CTL(cytotoxic T lymphocytes;细胞毒性T淋巴细胞)活性。结果成功构建Rv1733c的真核表达载体pcDNA-Rv1733c。间接免疫荧光实验表明pcDNA-Rv1733c质粒稳定转染的P815细胞中能够稳定表达Rv1733c蛋白。pcDNA-Rv1733c质粒DNA免疫小鼠后能诱导小鼠产生特异性抗体,抗体亚类以IgG2a为主,随着免疫时间的延长,IgG2a/IgG1的比值趋于平衡;脾淋巴细胞增殖指数(2.00±0.36)高于BCG组(1.1±0.06)(t=3.096,P<0.05);特异性分泌IFN-γ的脾淋巴细胞频数(41.48±5.30)SFC/106高于生理盐水组(2.75±1.37)SFC/106(t=4.752,P<0.05);然而脾淋巴细胞中CD4+、CD8+T细胞所占比率[分别为(18.15±2.30)%、(7.68±1.34)%]、CTL杀伤活性[(29.52±1.96)%]都与生理盐水组相当[(16.43±2.02)%(t=0.571,P>0.05)、(7.32±0.42)%(t=0.234,P>0.05)、(25.28±2.51)%(t=0.726,P>0.05)]。结论成功构建Rv1733c真核表达载体pcDNA-Rv1733c;并能够诱导小鼠机体产生特异性的体液和细胞免疫应答,提示用于结核病新型疫苗的研究具有一定的意义。 Objective To construct DNA vaccine of dormancy related antigen Rv1733c of Mycobacterium tu- berculosis (Mtb), and to evaluate its immunogenicity in mice. Methods Rv1733c gene was cloned into the eukar- yotic expression vector pcDNA 3.1 (--) from the plamid pMD-18T-Rv1733c, which was constructed previously and preserved in our lab. The constructed plasmid was named pcDNA-Rv1733c. P815 cells were stably transfected with the plasmid pcDNA-Rv1733c, and were detected the protein expression of Rv1733c by indirect immunofluorescence (IFT). The mice BALB/c were divided randomly into three groups named pcDNA-Rv1733c DNA, saline and BCG, 10 mice per group. The mice were immunized with pcDNA-Rv1733c DNA or saline intramuscularly 3 times at an in- terval of 2 weeks. BCG was immunized subcutaneously only once. The antigen specific antibody level and IgG2a/ IgG1 subtype ratio in immunized mice were detected by ELISA every 2 weeks, At 8 weeks after the first immuniza- tion, the specific proliferation of spleno-lymphocytes of mice was detected by MTS I-3-(4,5-diethylthiazol-2-yl)-5- (3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-etrazolium, inner salt] method, and IFN-T secreted by spleno- lymphocytes was detected by ELISPOT. The percentages of CD4+ and: CD8+ T cells in spleno-lymphocytes were an- alyzed by flow cytometry, and the function of cytotoxicity T lymphocyte (CTL) was detected by lactate dehydrogen-ase(LDH) assay. Restlits The eukaryotic expression plasmid of Rv1733c gene was successfully constructed, named peDNA-Rv1733c. In P815 cells stably transfected with peDNA-Rv1733c plasmid, the expression protein of Rv1733c could be stably detected by IFT. In immunized mice, the pcDNA-Rv1733c plasmid could stimulate the pro- duction of the antigen specific antibody, and the antibody subtype biased to IgG2a,but with the extension of immuni- zation time, the ratio of IgG2a/IgG1 was tended to balance. In pcDNA-Rv1733e DNA group, the stimulation index of spleno-lymphocytes was (2.00±0. 36), and the cell number of secreted IFN-± was (41.48±5.30) SFC/106 , which were both statistically higher than those in saline group (t=3. 096, P〈0.05). However, the percentages of CD4+ and CD8+ T ceils [(18.15±2.30)% and (7.68±1.34)%], and the activity of CTL [(29.52±1.96)%] were not significantly different with those in saline group(t=0. 571,P〉0. 05). Conclusion The eukaryotic ex- pression plasmid of Rv1733c was constructed successfully. The pcDNA-Rv1733c plasmid DNA could induce specific humoral and cellular immunity in mice. It may be used as the new TB vaccine against latent Mtb infection.
出处 《中国防痨杂志》 CAS 2013年第9期679-685,共7页 Chinese Journal of Antituberculosis
基金 "十二五"国家科技重大专项(2012ZX10003008-007) 国家自然科学基金(30801055)
关键词 分枝杆菌 结核 抗原 细菌 疫苗 DNA 抗体生成 免疫 细胞 Mycobacterium tuberculosis Antigens, bacterial Vaccines, DNA Antibody formation Immunity, cellular
  • 相关文献

参考文献11

  • 1World Health Organization. Tuberculosis[EB/OL]. Geneva= WHO, 2013 [2013-04-18]. http://www, who. int/mediacentre/faetsheets/fs104/en/index, html.
  • 2Voskuil MI. Mycobacterium tuberculosis gene expression during environmental conditions associated with latency. Tuberculosis (Edinb) ,2004,84(3/4) : 138-143.
  • 3Muttucumaru DG, Roberts G, Hinds J, et al. Gene expression profile of Mycobacterium tuberculosis in a non-replicating state. Tuberculosis (Edinb), 2004, 84 (3/4) : 239-246.
  • 4Leyten EM,Lin MY,Franken KL,et al. Human T-cell respon- ses to 25 novel antigens encoded by genes of the dormancy re gulon of Mycobacterium tuberculosis. Microbes Infect, 2006, 8 (8) : 2052-2060.
  • 5Lin MY,Geluk A,Smith SG,et al. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect Immun, 2007,75 (7) :3523-3530.
  • 6Black GF, Thiel BA, Ota MO,et al. Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tu- berculosis in three high-burden populations in Africa. Clin Vaccine Immunol,2009, 16(8) : 1203-1212.
  • 7张薇,柏银兰,康健,王平,徐志凯,王丽梅.结核分枝杆菌持续感染期抗原Rv1733c的表达、纯化和鉴定[J].现代生物医学进展,2012,12(10):1868-1871. 被引量:6
  • 8吴雪琼.新型结核病疫苗的研究现状与发展趋势[J].中国防痨杂志,2012,34(3):133-137. 被引量:21
  • 9Huygen K. On the use of DNA vaccines for the prophylaxis of Mycobacterial diseases. Infect Immun, 2003,71 (4) : 1613-1621.
  • 10RoupieV,RomanoM,ZhangLo Immunogenicity of eight dormancy regulon-encoded proteins of Mycobactehum tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect Immun,2007,75 (2):941-949.

二级参考文献26

  • 1Scriba TJ, Tameris M, Mansoor N, et al. Modified vaccinia Ankara expressing Ag85A, a novel tuberculosis vaccine, issafe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur J Immunol, 2010, 4,0(1) : 279-290.
  • 2Miki K, Nagata T, Tanaka T, et al. Induction of protective cellular immunity against Mycobacterium tuberculosis by recom- binant attenuated self destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids For antigen 85 complex and MPB/MPT51. Infect Immun, 2004, 72 (4): 2014 2021.
  • 3Pavelka MS Jr, Jacobs WR Jr. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacte-rium boris bacillus Calmette Guerin, and Mycobacte- rium tuberculosis H37Rv by allelic exchange. J Bacteriol, 1999, 181(16):4780-4789.
  • 4van Dissel JT, Arend SM, Prins C, et al. Ag85B-ESAT -6 ad juvanted with IC31 promotes strong and long lived Mycobacte- rium tuberculosis specific T cell responses in naive human volunteers. Vaccine, 2010, 28(20) :3571 -3581.
  • 5Dietrich J, Aagaard C, I.eah R, et al. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule based tuberculosis subunit vaccine: efficient protection and ESAT6 based sensi- tive monitoring of vaccine efficacy. J Immunol, 2005,174 (10) : 6332-6339.
  • 6Wright A, Zignol M, Van Deun A, et al. Epidemiology of antituberculosis drug resistance 2002-2007: an updated analysis of the global project on anti-tuberculosis drug resistance surveillance [J]. Lancet, 2009, 373:1861-1873.
  • 7Flynn JL, Chan J. Tuberculosis: latency and reactivation [J]. Infect Immun, 2001, 69(7): 4195-4201.
  • 8Christopher Dye. Global epidemiology of tuberculosis [J]. Lancet 2006; 367:938-940.
  • 9Wayne LG, Sohaskey CD. Nonreplicating persistence of mycobacterium tuberculosis [J]. Annu Rev Microbiol, 2001, 55:139-163.
  • 10Lin MY, Geluk A, Smith SGL. Lack of immune responses to mycobacterium tuberculosis DosR regulon proteins following mycobacterium bovis BCG vaccination [J]. Infect. Immun, 2007,75 (7): 3523-3530.

共引文献25

同被引文献36

  • 1中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年).北京:人民卫生出版社,2010:4.
  • 2Zhao Y, Xu S, Wang L, et al. National survey of drug-resis- tant tuberculosis in China. N Engl J Med, 2012, 366 (23): 2161-2170.
  • 3No authors listed. Streptomycin treatment of pulmonary tu- berculosis. A medical research council investigation. Br Med J, 1948,2(4582) : 769-782.
  • 4Gandotra S, Schnappinger D, Monteleone M, et al. In vivo gene silencing identifies the Mycobacterium tuberculosis protea- some as essential for the bacteria to persist in mice. Nat Med, 2007,13 (12) : 1515-1520.
  • 5MacMieking JD. M. tuberculosis passes the litmus test. Nat Med, 2008,14 (8) : 809-810.
  • 6Demartino GN, Gillette TG. Proteasomes: machines for all reasons. Ce11,2007,129(4), 659-662.
  • 7Darwin KH, Ehrt S, Gutierrez-Ramos JC, et al. The protea- some of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science,2003,302(5652), 1963-1966.
  • 8Gill WP, Harik NS, Whiddon MR, et al. A replication clock for Mycobacterium tuberculosis. Nat Med, 2009, 15 (2):211-214.
  • 9Dye C, Scheele S, Dolin P,et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monito ring Project. JAMA,1999,282(7) :677-686.
  • 10Lonnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet,2010,375(9728):1814-1829.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部